The requirement for prescriptions for controlled substances written by physician assistants to include the name of the supervising physician is increasingly outdated and creates unnecessary administrative complexity without improving patient safety. Each PA already has a unique DEA registration number and National Provider Identifier (NPI), which clearly identifies the prescribing clinician and provides full traceability and accountability. Including the care team physician’s name therefore adds redundancy rather than meaningful oversight. Requiring the physician’s name on the prescription can cause confusion at pharmacies, delay medication dispensing, and create avoidable administrative burdens for both providers and pharmacists. Removing the supervising physician name requirement would align Virginia with modern team-based care models and with practices adopted in many other states. PAs in Virginia would continue to practice under collaborative agreements and remain subject to all applicable prescribing laws, DEA regulations, and state oversight. Overall, removing this requirement would streamline clinical workflows, reduce confusion at pharmacies, and better reflect the modern role of PAs in delivering safe, high-quality patient care.